BESUNYEN (00926) has released its interim results for the six months ended June 30, 2026. The company recorded revenue of RMB 305 million (same unit below), representing a year-on-year increase of 17.74%. Net profit reached 15.066 million yuan, reflecting a 21.48% rise compared to the same period last year. Basic earnings per share stood at 0.12 yuan.

The company attributed the revenue growth primarily to the strong performance of its four-tea product line, which saw a substantial 43.8% increase in revenue. However, this growth was partially offset by a decline in sales of other pharmaceutical products and health supplements.